COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside
COVID-19 и возможная связь с болезнью Паркинсона и паркинсонизмом: от лаборатории к клинической практике
2020-08-20
SCID: 54.1/q6h6gdqv
Discuss with AI
Angiotensin-converting enzyme 2COVID-19HyposmiaParkinson’s diseaseSARS-CoV-2 neuroinvasion
Figures from the paper
Abstract (AI)
This Viewpoint discusses insights from basic science and clinical perspectives on coronavirus disease 2019 (COVID-19)/severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection in the brain, with a particular focus on Parkinson's disease. Major points include that neuropathology studies have not answered the central issue of whether the virus enters central nervous system neurons, astrocytes or microglia, and the brain vascular cell types that express virus have not yet been identified. Currently, there is no clear evidence for human neuronal or astrocyte expression of angiotensin-converting enzyme 2 (ACE2), the major receptor for viral entry, but ACE2 expression may be activated by inflammation, and a comparison of healthy and infected brains is important. In contrast to the 1918 influenza pandemic and avian flu, reports of encephalopathy in COVID-19 have been slow to emerge, and there are so far no documented reports of parkinsonism apart from a single case report. We recommend consensus guidelines for the clinical treatment of Parkinson's patients with COVID-19. While a role for the virus in causing or exacerbating Parkinson's disease appears unlikely at this time, aggravation of specific motor and non-motor symptoms has been reported, and it will be important to monitor subjects after recovery, particularly for those with persisting hyposmia.
Key Findings
1
A causal role for SARS-CoV-2 in initiating or worsening Parkinson’s disease appears unlikely currently, but specific motor and non-motor symptoms may be aggravated.
2
Compared with prior influenza pandemics, encephalopathy reports in COVID-19 emerged slowly, with only one documented case of parkinsonism reported at the time.
3
Consensus clinical-treatment guidelines are recommended for Parkinson’s patients with COVID-19, with post-recovery monitoring especially important for individuals with persistent hyposmia.
4
Neuropathology studies have not established whether SARS-CoV-2 infects central nervous system neurons, astrocytes, or microglia, nor which brain vascular cells express the virus.
5
There is currently no clear evidence of ACE2 expression in human neurons or astrocytes, although inflammation may activate ACE2 expression in the brain.
Research Object
COVID-19/SARS-CoV-2 infection in the brain, with a focus on Parkinson’s disease and parkinsonism
Research Subject
Neuroinvasion, neuropathological mechanisms, and clinical motor and non-motor effects, including the potential link to Parkinson’s disease and parkinsonism
Publication Details
Publication Date
2020-08-20
Journal
Publisher
ISSN
Cited by
175
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai13
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China2020
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China2020
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis2004
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic2020
The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients2020
A first case of meningitis/encephalitis associated with SARS-Coronavirus-22020
Guillain–Barré Syndrome Associated with SARS-CoV-22020
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction2020
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings2020
Zoonotic origins of human coronaviruses2020
Central nervous system involvement by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)2020
Autopsy Findings and Venous Thromboembolism in Patients With COVID-192020
Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models2020